Table 3.

Candidates for 51 and 53 exon skipping for restoration of dystrophin expression (source: www.clinicaltrials.gov )

51 exon skipping			53 exon skipping
Deleted exon(s)	No. of individuals	% of registrants	Deleted exon(s)	No. of individuals	% of registrants
45-50	8	3.5%	52	3	1.3%
47-50	2	0.9%	47-52	1	0.4%
48-50	4	1.7%	48-52	3	1.3%
49-50	2	0.9%	49-52	2	0.9%
50	2	0.9%	50-52	1	0.4%
52	3	1.3%
52-63	0	0%
Total	21	9.2%		10	4.3%